Heron Therapeutics Inc (NAS:HRTX)
$ 3.6 -0.03 (-0.83%) Market Cap: 542.35 Mil Enterprise Value: 650.00 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 61/100

Q1 2024 Heron Therapeutics Inc Earnings Call Transcript

May 07, 2024 / 12:30PM GMT
Release Date Price: $2.87 (+1.06%)
Operator

Thank you for standing by. My name is Alex, and I will be your conference operator today. At this time, I would like to welcome everyone to the Heron Therapeutics Q1 2024 conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session.

If you would like to ask a question during this time, simply press star followed by a number one on your telephone keypad. If you would like to withdraw your question, press star one. Again, I would now like to turn the call over to Melissa Jerome, executive director, legal. Please go ahead.

Unidentified Company Representative

Thank you, operator, and good morning, everyone. Thank you for joining us on the Heron Therapeutics conference call this morning to discuss the Company's financial results for the quarter ended March 31st, 2024. With me today from hereon are Craig Collard, Chief Executive Officer, Aaron to RK, Executive Vice President and Chief Financial Officer, Bill Forbes, Executive Vice President and Chief Development Officer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot